RFPs: Distinguished Investigator – Bioscience and Basic Biomedicine Program (Denmark)

The Novo Nordisk Foundation offers the Distinguished Investigator Grant for research leaders in bioscience and basic biomedicine. This grant supports high-impact scientific research in Denmark, with an application deadline of 12 January 2027. The Distinguished Investigator Grant aims to support fundamental research in bioscience and basic biomedicine. Its focus is on projects that advance understanding of the human organism and the mechanisms underlying health and disease. The grant encourages innovative research with the potential for significant scientific impact.

Supported research fields include:

Research can be conducted using animal, cellular, subcellular, or in silico models. This grant supports leading-edge research that can significantly advance scientific knowledge in bioscience and basic biomedicine. It provides substantial funding to facilitate groundbreaking projects and foster international collaborations. What is the maximum funding available per grant? Each grant can provide up to DKK 12.5 million over five years. Who is eligible to apply for this grant? The grant is targeted at established professors with a strong record of scientific achievements. What research areas are prioritized? Research in bioscience and basic biomedicine, including molecular biology, genetics, and pharmacology, among others, is prioritized. What is the deadline for application submission? Applications must be submitted by 12 January 2027, 2:00 pm (Copenhagen time). How can I submit my application? Applications should be submitted via the Foundation’s electronic application system. Interested and eligible applicants should thoroughly review the official guidelines and submit their proposals through the specified application system by the deadline. For further information, contact the grant manager or visit the Novo Nordisk Foundation’s opportunity page.